Pathogenesis of autoimmune hepatitis

Clinics in Liver Disease

Volumn 6, Issue 3, 2002, Pages 439-449

  Vergani, Diego ^a   Choudhuri, Kaushik ^a   Bogdanos, Dimitrios P ^a   Mieli Vergani, Giorgina ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKINE;

ANTIGEN RECOGNITION; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CROSS REACTION; CYTOKINE PRODUCTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0036694470     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1089-3261(02)00018-1     Document Type: Review

References (50)

1. De Groote J, Desmet VJ, Gedigk P, et al. A classification of chronic hepatitis. Lancet 1968; 2:626-8.
2. Scheuer P. Chronic aggressive hepatitis. In: Liver biopsy interpretation. 2nd edition. London: Balliere Tindall; 1974. p. 68-72.
3. Senaldi G, Portmann B, Mowat AP, et al. Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis. Arch Dis Child 1992;67:1447-53.
4. Abo T, Kawamura T, Watanabe H. Physiological responses of extrathymic T cells in the liver. Immunol Rev 2000;174:135-49.
5. Takeda K, Hayakawa Y, Van Kaer L, et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000;97:5498-503.
6. Nouri-Aria KT, Donaldson PT, Hegarty JE, et al: HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis. J Hepatol 1985;1: 235-41.
7. Nouri-Aria KT, Lobo-Yeo A, Vergani D, et al. T suppressor cell function and number in children with liver disease. Clin Exp Immunol 1985;61:283-9.
8. Donaldson PT, Doherty DG, Hayllar KM, et al. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13:701-6.
9. Nouri-Aria KT, Hegarty JE, Alexander GJ, et al. Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis. N Engl J Med 1982;307:1301-4.
10. Vento S, Hegarty JE, Bottazzo G, et al. Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet 1984;1:1200-4.
11. Lobo-Yeo A, Senaldi G, Portmann B, et al. Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease. Hepatology 1990;12: 224-32.
12. Chen M, Shirai M, Liu Z, et al. Efficient class II major histocompatibility complex presentation of endogenously synthesized hepatitis C virus core protein by Epstein-Barr virus-transformed B-lymphoblastoid cell lines to CD4(+) T cells. J Virol 1998;72:8301-8.
13. Lobo-Yeo A, Alviggi L, Mieli-Vergani G, et al. Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis. Clin Exp Immunol 1987;67:95-104.
14. Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev. 2000;174:250-259
15. Wen L, Peakman M, Lobo-Yeo A, et al. T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis. Lancet 1990;336:1527-30.
16. Jensen DM, McFarlane IG, Portmann BS, et al. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 1978;299:1-7.
17. McFarlane BM, McSorley CG, Vergani D, et al: Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 1986;3:196-205.
18. Ma Y, Gaken J, McFarlane BM, et al. Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease. Gastroenterology 1997;112:483-92.
19. Vergani D, Mieli-Vergani G, Mondelli M, et al. Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage. Liver 1987;7:307-15.
20. Mieli-Vergani G, Vergani D, Jenkins PJ, et al: Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol 1979;38:16-21.
21. Wen L, Ma Y, Bogdanos DP, et al: Paediatric autoimmune liver disease: the molecular basis of humoral and cellular immunity. Curr Mol Med 2001;1:379-89.
22. Lohr H, Manns M, Kyriatsoulis A, et al. Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol 1991;84: 297-302.
23. Lohr H, Treichel U, Poralla T, et al. Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro. Clin Exp Immunol 1992;88:45-9.
24. Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol 1996;14:1-27.
25. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 1998;12:1255-65.
26. Bogdanos DP, Choudhuri K, Vergani D: Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 2001;21:225-32.
27. Gross DM, Forsthuber T, Tary-Lehmann M, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998;281:703-6.
28. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80: 695-705.
29. Zhao ZS, Granucci F, Yeh L, et al. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 1998;279:1344-7.
30. Bogdanos DP, Mieli-Vergani G, Vergani D: Virus, liver and autoimmunity. Dig Liver Dis 2000; 32:440-6.
31. Gregorio GV, Choudhuri K, Ma Y, et al: Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol 1999;162:1802-10.
32. Kammer AR, van der Burg SH, Grabscheid B, et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med 1999; 190: 169-76.
33. Manns MP, Griffin KJ, Sullivan KF, et al. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991;88:1370-78.
34. Shimoda S, Nakamura M, Ishibashi H, et al. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995;181:1835-45.
35. Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987;7: 1333-9.
36. Gueguen M, Meunier-Rotival M, Bernard O, et al: Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily. J Exp Med 1988;168:801-806
37. Muratori L, Parola M, Ripalti A, et al. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 2000;46:553-61.
38. Vergani D. LKM antibody: getting in some target practice. Gut 2000;46:449-50.
39. Lenzi M, Ballardini G, Fusconi M, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990;335:258-9.
40. Muratori L, Lenzi M, Cataleta M, et al. Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 1994;21:199-203.
41. Vergani D, Mieli-Vergani G. Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6. Clin Exp Immunol 1993;92:367-8.
42. Yamamoto AM, Cresteil D, Boniface O, et al. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-I antibodies (LKM1). Eur J Immunol 1993;23:1105-11.
43. Klein R, Zanger UM, Berg T, et al. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes. Clin Exp Immunol 1999;118:290-7.
44. Aichele P, Bachmann MF, Hengartner H, et al. Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol Rev 1996;152:21-45.
45. Galvin JE, Hemric ME, Ward K, et al. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 2000;106:217-24.
46. Cunha-Neto E, Coelho V, Guilherme L, et al. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 1996;98:1709-12.
47. Gregorio GV, Portmann B, Reid F, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997;25:541-7.
48. Choudhuri K, Gregorio GV, Mieli-Vergani G, et al. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis. Hepatology 1998;28:1177-81.
49. Ahonen P, Myllarniemi S, Sipila I, et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 1990;322: 1829-36.
50. Nagamine K, Peterson P, Scott HS, et al. Positional cloning of the APECED gene. Nat Genet 1997;17:393-8.